← Return to Promising news on targeting KRAS G12D mutations

Discussion

Promising news on targeting KRAS G12D mutations

Pancreatic Cancer | Last Active: Mar 23 11:08pm | Replies (4)

Comment receiving replies
@gamaryanne

KRAS G12D TRIAL RECRUITING in 6 locations. This is not immunotherapy trial at John’s Hopkins and other places.

Check out Revolution Medicine in San Diego. Trial 9805.
It is in phase 1b and will recruiting for about 6 more weeks. It is close to Phase 2.

Doctor I consulted with said it is looking very good and has the ability to “turn off” this mutation (sorry-I am far from a medical expert so layman’s terms!).

Jump to this post


Replies to "KRAS G12D TRIAL RECRUITING in 6 locations. This is not immunotherapy trial at John’s Hopkins and..."

Thank you, that is encouraging!